Valhi Inc. (VHI)
NYSE NYSE Primary 
Valhi Q2 Earnings Surge Y/Y as Chemical Volumes, Margins Improve
VHI's Q2 earnings jump y/y as higher TiO2 volumes, lower costs and wider margins lift the results, supporting an improved 2026 operating outlook.
Zacks Initiates Coverage of VHI With Underperform Recommendation
Discover why Zacks, being the first on Wall Street to initiate coverage of the stock, rates Valhi as "Underperform." Explore how VHI's pricing pressure, weak demand and rising costs could weigh on earnings and limit upside potential.
Valhi: Lower Selling Prices And Volumes
Valhi (VHI) faces headwinds from lower TiO2 prices and destocking on volumes, pressuring its chemical segment despite a positive perimeter effect from a joint venture buyout. Operating income declined due to falling TiO2 prices, stable input costs and general operating leverage on lower industrial volumes. A higher CAPEX commitment and weak market environment have reduced the NAV discount to just 4%.
